Login to Your Account



Clinical Data Boosts Pipeline with Adenosine Buyout

By Donna Young


Wednesday, August 6, 2008
At a relatively low price of $11 million in cash and a $22 million five-year promissory note to buy Adenosine Therapeutics LLC, Clinical Data Inc. went literally overnight from a one-drug firm to a company with several therapeutic candidates in its pipeline. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription